Smoke, GPx activity and symptoms improvement in patients with drug-naive first-episode schizophrenia: A large-scale 12-week follow-up study

Addington, 1998, Smoking cessation treatment for patients with schizophrenia, Am. J. Psychiatry, 155, 974, 10.1176/ajp.155.7.974 Ahmadi-Motamayel, 2017, Evaluation of salivary catalase, vitamin C, and alpha-amylase in smokers and non-smokers: a retrospective cohort study, J. Oral. Pathol. Med., 46, 377, 10.1111/jop.12495 Bai, 2013, Homozygous deletion of glutathione peroxidase 1 and aldehyde dehydrogenase 1a1 genes is not associated with schizophrenia-like behavior in mice, J. Biochem Pharm. Res, 1, 228 Ballesteros, 2013, No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia, Schizophr. Res, 146, 184, 10.1016/j.schres.2013.02.001 Bošković, 2011, Oxidative stress in schizophrenia, Curr. Neuropharmacol., 9, 301, 10.2174/157015911795596595 Brigelius-Flohé, 1999, Tissue-specific functions of individual glutathione peroxidases, Free Radic. Biol. Med, 27, 951, 10.1016/S0891-5849(99)00173-2 Camera, 2002, Analytical methods to investigate glutathione and related compounds in biological and pathological processes, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 781, 181, 10.1016/S1570-0232(02)00618-9 Caruso, 2020, Antioxidant properties of second-generation antipsychotics: focus on microglia, Pharmaceuticals, 13 Cecerska-Heryć, 2021, Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review, Neurochem. Int., 153 Changeux, 2010, Nicotine addiction and nicotinic receptors: lessons from genetically modified mice, Nat. Rev. Neurosci., 11, 389, 10.1038/nrn2849 Ding, 2021, Cigarette smoking and schizophrenia: etiology, clinical, pharmacological, and treatment implications, Schizophr. Res. Treat., 2021 Dome, 2010, Smoking, nicotine and neuropsychiatric disorders, Neurosci. Biobehav. Rev., 34, 295, 10.1016/j.neubiorev.2009.07.013 Drew, 2000, Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex, Synapse, 38, 10, 10.1002/1098-2396(200010)38:1<10::AID-SYN2>3.0.CO;2-T Glassman, 1993, Cigarette smoking: implications for psychiatric illness, Am. J. Psychiatry, 150, 546, 10.1176/ajp.150.4.546 Goh, 2022, Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: a meta-analysis, Asian J. Psychiatr., 67, 10.1016/j.ajp.2021.102932 Grenhoff, 1986, Nicotinic effects on the firing pattern of midbrain dopamine neurons, Acta Physiol. Scand., 128, 351, 10.1111/j.1748-1716.1986.tb07988.x Guan, 2003, Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells, Neurochem. Int., 43, 243, 10.1016/S0197-0186(03)00009-3 Isik, 2007, Oxidative stress in smokers and non-smokers, Inhal. Toxicol., 19, 767, 10.1080/08958370701401418 James, 2000, Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease, Circulation, 101, 2252, 10.1161/01.CIR.101.19.2252 Jordan, 2018, Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders, Eur. Arch. Psychiatry Clin. Neurosci., 268, 129, 10.1007/s00406-016-0749-7 Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr. Bull., 13, 261, 10.1093/schbul/13.2.261 Kirkham, 2006, Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy, Pharm. Ther., 111, 476, 10.1016/j.pharmthera.2005.10.015 Knight, 2000, Review: Free radicals, antioxidants, and the immune system, Ann. Clin. Lab Sci., 30, 145 Li, 2021, Altered antioxidant defenses in drug-naive first episode patients with schizophrenia are associated with poor treatment response to risperidone: 12-Week results from a prospective longitudinal study, Neurotherapeutics, 10.1007/s13311-021-01036-3 Liu, H., R. Yu, Y. Gao, X. Li, X. Guan, K. Thomas, M. Xiu and X. Zhang, 2021b. Antioxidant enzymes and weight gain in drug-naive first episode schizophrenia patients treated with risperidone for 12 weeks: a prospective longitudinal study. Curr Neuropharmacol. Liu, H., H. Liu, S. Jiang, L. Su, Y. Lu, Z. Chen, X. Li, X. Li, X. Wang, M. Xiu, X. Zhang, 2021a. Sex-specific association between antioxidant defense system and therapeutic response to risperidone in schizophrenia: a prospective longitudinal study. Curr Neuropharmacol. Lucatch, 2018, Neurobiological determinants of tobacco smoking in schizophrenia, Front. Psychiatry, 9, 672, 10.3389/fpsyt.2018.00672 Macnee, 1999, Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 160, S58, 10.1164/ajrccm.160.supplement_1.15 MacNee, 2000, Oxidants/antioxidants and COPD, Chest, 117, 303s, 10.1378/chest.117.5_suppl_1.303S-a Möller, 2015, Pharmacological treatment of negative symptoms in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 265, 567, 10.1007/s00406-015-0596-y Montuschi, 2000, Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers, Am. J. Respir. Crit. Care Med., 162, 1175, 10.1164/ajrccm.162.3.2001063 Murray, 2021, Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders, Front. Psychiatry, 12, 10.3389/fpsyt.2021.703452 Nomikos, 2000, Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness, Behav. Brain Res, 113, 97, 10.1016/S0166-4328(00)00204-7 Raffa, 2011, Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients, BMC Psychiatry, 11, 124, 10.1186/1471-244X-11-124 Rangasamy, 2004, Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice, J. Clin. Investig., 114, 1248, 10.1172/JCI200421146 Šagud, 2018, Smoking in schizophrenia: an updated review, Psychiatr. Danub, 30, 216 Sato, 2014, Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells, Stem Cell Res., 12, 119, 10.1016/j.scr.2013.09.012 Stojković, 2012, Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain, Prog. Neuropsychopharmacol. Biol. Psychiatry, 39, 192, 10.1016/j.pnpbp.2012.06.013 Williams, 2005, Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect, Schizophr. Res., 79, 323, 10.1016/j.schres.2005.04.016 Wu, 2013, Free radicals, antioxidant defense systems, and schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 46, 200, 10.1016/j.pnpbp.2013.02.015 Xiu, 2020, Interrelationships between BDNF, superoxide dismutase, and cognitive impairment in drug-naive first-episode patients with schizophrenia, Schizophr. Bull., 10.1093/schbul/sbaa062 Yao, 2006, Altered glutathione redox state in schizophrenia, Dis. Markers, 22, 83, 10.1155/2006/248387 Zhang, 2006, Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics, Schizophr. Res., 81, 291, 10.1016/j.schres.2005.10.011 Zhang, 2007, Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia, Neuropsychopharmacology, 32, 2020, 10.1038/sj.npp.1301317